Clinical trials are becoming increasingly complex and competitive, so attracting the best investigator sites to participate in a trial is a crucial step in meeting patient enrollment targets.
Delaying approval by even one day can cost hundreds of thousands of dollars or more, depending on the drug. This means that timely trial implementation, including patient enrollment, may add significant value.
Meeting patient enrollment milestones in cooperation with investigators has traditionally been viewed as the responsibility of the contract research organization (CRO). Now, important new data show that a sponsor’s choice of a central lab impacts the willingness of investigators to work with a sponsor on clinical trials. Continue reading
Introducing a drug into the human body for the first time is an important milestone. Considerable investment goes into preparing for this day, with more to follow — 70% of the R&D cost needed to bring a drug to market is spent after Phase I. With so much at stake, human safety and early efficacy are now driving more go/no-go decisions than ever before.
Early Clinical Research Centers
With clinic locations throughout the US and Europe, we recruit a diverse healthy and patient population to participate in your clinical study. You have access to over 350 beds for fast and flexible study startup and a dedicated team of recruiting specialists for success in filling panels. In addition to the stability and reputation for quality that underscores all clinic operations, each clinical research unit offers you specialized capabilities such as a glucose clamp unit in Dallas, a human appetite lab in Leeds, and a dedicated cGMP pharmacy support team for radiolabeled AME studies in Madison. A clinical site will be selected based on your study needs and preferences, site experience conducting similar studies and site capacity. For more information about the clinics, please visit our website. Continue reading